Dermatology Times E-News :
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Dermatology Times E-News
Modern Medicine Network
TOP SEARCHES: Alopecia // Hyperpigmentation // Atopic dermatitis
In this issue
CMS helps delay cuts
Panel weighs tanning risks
FDA OKs Differin lotion
Zyclara wins nod for AK
Tougher warnings needed?
Derm donates $100K
Gel combats wound pain
Key Topic Updates

Contact Us
Click here to contact a Dermatology Times editor.

Click here to contact a Dermatology Times sales representative.

Click here to learn about direct mail, reprints and classifieds in Dermatology Times.

Follow us on Twitter

APRIL 7, 2010

CMS buys time on Medicare reimbursement cut
Washington — Though Congress adjourned for recess without taking action to forestall the 21 percent cut in Medicare reimbursement that took effect April 1, the Centers for Medicare and Medicaid Services (CMS) has acted to buy doctors more time, MedPage Today reports. [Also see Elizabeth Woodcock’s updated “Minding Your Practice” blog on Modern Medicine.] More...

FDA mulls tanning bed ban for teens
Gaithersburg, Md. — A panel of advisers to the Food and Drug Administration (FDA) has recommended that the agency place tighter controls on artificial tanning, the Associated Press reports. Those controls could range from requiring parental consent forms to banning the practice in teens under age 18. More...
FDA approves adapalene lotion for acne
Fort Worth, Texas — The Food and Drug Administration (FDA) has approved the lotion formulation of adapalene (Differin 0.1 percent, Galderma) for the topical treatment of acne in patients age 12 and older, Medscape Today reports. More...
Actinic keratoses cream gets thumbs-up
Bristol, Tenn. — The Food and Drug Administration (FDA) has approved Zyclara, a new cream made by Bristol, Tenn.-based Graceway Pharmaceuticals, for treatment of actinic keratoses, news source TriCities.com reports. More...
Eczema creams may require expanded warnings
Washington — The Food and Drug Administration (FDA) says Novartis AG and Astellas Pharma may need to expand warning labels on their eczema drugs following dozens of new reported cases of cancer and infection in children, Reuters reports. More...
Derm’s new fund supports exchange programs
Rolling Meadows, Ill. — Lawrence Field, M.D., has donated $100,000 to the American Society for Dermatologic Surgery (ASDS) to start the Lawrence Field, M.D., International Dermatologic Surgery Educational Exchange Fund. More...
New gel combats itching, pain from certain wounds
Petaluma, Calif. — Medical technology company Oculus Innovative Sciences is bringing Microcyn Dermatology HydroGel to the U.S. market, Business Wire reports. More...
Key Topic Updates  
Liability & Risk Management
Attorneys can be your allies
Physicians attribute higher costs to defensive medicine
Health Law & Policy
Make your office accessible to all
What the HITECH Act means for you
Skin Cancer
Nonmelanoma skin cancer an ‘epidemic’
Melanoma survivors face high second primary cancer risk
Career Opportunities

Lahey Clinic Medical Center
General Dermatology

Dermatology Associates of Lancaster
BC/BE Dermatologist-Pennsylvania
Associates in Dermatology
BC/BE Dermatologist
Renuka Bhatt, MD
Dermatologists Needed
Cejka Search
Dermatologist-Idaho’s Rocky Mountain Foothills
Avenues Dermatology
Dermatologist
Watson Clinic, LLP
Dermatopathology Opportunity in Florida
Huntington Dermatology and Cosmetic Associates, PC
Dermatologist-Long Island, NY

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar
Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.